Literature DB >> 10698198

Involvement of insulin-like growth factors in early T cell development: a study using fetal thymic organ cultures.

O Kecha1, F Brilot, H Martens, N Franchimont, C Renard, R Greimers, M P Defresne, R Winkler, V Geenen.   

Abstract

The expression of insulin-like growth factor (IGF) and IGF receptor genes was investigated by RT-PCR during ontogeny of the murine thymus. IGF-1, IGF-1R, M6P/IGF-2R genes are expressed in the thymus both in fetal and postnatal life, whereas IGF-2 messenger RNAs (mRNAs) decline after birth but are still detectable on the seventh week. By in situ hybridization, IGF-2 transcripts were located in the outer cortex and medulla of the postnatal thymus, and on the whole surface ofthe epithelial-like network in the fetal thymus. The effects of anti-IGFs and IGF-receptors neutralizing Abs on the generation of pre-T cell subpopulations were then investigated using fetal thymic organ cultures (FTOC). FTOC treatment with an anti-IGF-2 mAb, an anti-IGF-1R mAb, or an anti-M6P/IGF-2R polyclonal Ab induced a blockade of T cell differentiation at the CD4-CD8- stage, as shown by a significant increase in the percentage of CD4-CD8- cells and a decrease in the percentage of CD4+CD8+ cells. Moreover, anti-IGF-2 Ab treatment induced an increase in CD8+ cells suggesting that thymic IGF-2 might have a role in determining differentiation into the CD4 or CD8 lineage. Anti-IGF-1 Ab treatment decreased the proportion in CD4-CD8- cells and increased the frequency in CD4+CD8+. FTOC treatment with anti-(pro)insulin did not exert any significant effect on T cell development. These data indicate that the intrathymic IGF-mediated signaling plays an active role in the early steps of T cell differentiation during fetal development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698198     DOI: 10.1210/endo.141.3.7360

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus.

Authors:  M C Erlandsson; C Ohlsson; J A Gustafsson; H Carlsten
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

Review 2.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

3.  Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor.

Authors:  Hela Jaïdane; Delphine Caloone; Pierre-Emmanuel Lobert; Famara Sane; Olivier Dardenne; Philippe Naquet; Jawhar Gharbi; Mahjoub Aouni; Vincent Geenen; Didier Hober
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

Review 4.  Emerging strategies to boost thymic function.

Authors:  Georg A Holländer; Werner Krenger; Bruce R Blazar
Journal:  Curr Opin Pharmacol       Date:  2010-05-04       Impact factor: 5.547

5.  Infectious diseases and immunological responses in adult subjects with lifetime untreated, congenital GH deficiency.

Authors:  Viviane C Campos; Mônica R Barrios; Roberto Salvatori; Roque Pacheco de Almeida; Enaldo V de Melo; Ana C S Nascimento; Amélia Ribeiro de Jesus; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2016-08-03       Impact factor: 3.633

Review 6.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 7.  Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

Authors:  Hyun Lee; So Ri Kim; Youngman Oh; Seong Ho Cho; Robert P Schleimer; Yong Chul Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

8.  Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion.

Authors:  Yu-Waye Chu; Sabrina Schmitz; Baishakhi Choudhury; William Telford; Veena Kapoor; Susan Garfield; David Howe; Ronald E Gress
Journal:  Blood       Date:  2008-07-24       Impact factor: 22.113

9.  Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A.

Authors:  Abbe N Vallejo; Joshua J Michel; Laurie K Bale; Bonnie H Lemster; Lisa Borghesi; Cheryl A Conover
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

10.  Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients.

Authors:  Gabriel Morrhaye; Hamid Kermani; Jean-Jacques Legros; Frederic Baron; Yves Beguin; Michel Moutschen; Remi Cheynier; Henri J Martens; Vincent Geenen
Journal:  PLoS One       Date:  2009-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.